Achieve Life Sciences (ACHV)
(Delayed Data from NSDQ)
$4.93 USD
+0.04 (0.72%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $4.94 +0.02 (0.30%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Earnings Date | *AMC8/13/24 |
---|---|
Current Quarter | -0.22 |
EPS Last Quarter | -0.26 |
Last EPS Surprise | -8.33% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.04 |
Next Year | -0.99 |
EPS (TTM) | -1.29 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.22 | -0.25 | -1.04 | -0.99 |
# of Estimates | 2 | 2 | 3 | 2 |
Most Recent Consensus | -0.21 | -0.22 | -0.85 | NA |
High Estimate | -0.21 | -0.22 | -0.85 | -0.93 |
Low Estimate | -0.23 | -0.28 | -1.18 | -1.04 |
Year ago EPS | -0.43 | -0.34 | -1.50 | -1.04 |
Year over Year Growth Est. | 48.84% | 26.47% | 30.67% | 5.61% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.22 | -0.25 | -1.04 | -0.99 |
7 Days Ago | -0.22 | -0.25 | -1.04 | -0.99 |
30 Days Ago | -0.22 | -0.25 | -1.04 | -0.99 |
60 Days Ago | -0.22 | -0.25 | -1.04 | -0.99 |
90 Days Ago | -0.22 | -0.28 | -0.94 | -0.88 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.22 | -0.25 | -1.04 | -0.99 |
Zacks Consensus Estimate | -0.22 | -0.25 | -1.04 | -0.99 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.26 | -0.26 | -0.34 | -0.43 | NA |
Estimate | -0.24 | -0.32 | -0.34 | -0.41 | NA |
Difference | -0.02 | 0.06 | 0.00 | -0.02 | 0.01 |
Surprise | -8.33% | 18.75% | 0.00% | -4.88% | 1.39% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more